National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

2-methoxyestradiol
An orally bioavailable estradiol metabolite with potential antineoplastic activity. 2-Methoxyestradiol inhibits angiogenesis by reducing endothelial cell proliferation and inducing endothelial cell apoptosis. This agent also inhibits tumor cell growth by binding to tubulin, resulting in antimitotic activity, and by inducing caspase activation, resulting in cell cycle arrest in the G2 phase, DNA fragmentation, and apoptosis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:2-ME
2-Methoxy Estradiol
US brand name:Panzem
Abbreviation:2ME2
Chemical structure name:(17beta)-2-Methoxyestra-1,3,5(10)-triene-3,17-diol



Previous:1-methyl-d-tryptophan, 11C topotecan, 17-dimethylaminoethylamino-17-demethoxygeldanamycin, 18F-FHBG, 18F-fluoromisonidazole
Next:3'-deoxy-3'-[18F]fluorothymidine, 3,4-methylenedioxymethamphetamine, 3-deazauridine, 4'-iodo-4'-deoxydoxorubicin, 4-hydroxytamoxifen

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov